Arete Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$457K Buy
9,863
+396
+4% +$18.3K 0.03% 434
2025
Q1
$577K Buy
9,467
+1,721
+22% +$105K 0.04% 349
2024
Q4
$438K Buy
7,746
+2,247
+41% +$127K 0.03% 447
2024
Q3
$284K Sell
5,499
-3,289
-37% -$170K 0.02% 539
2024
Q2
$365K Sell
8,788
-3,766
-30% -$156K 0.03% 482
2024
Q1
$679K Sell
12,554
-480
-4% -$25.9K 0.06% 268
2023
Q4
$669K Buy
13,034
+435
+3% +$22.3K 0.05% 335
2023
Q3
$731K Sell
12,599
-10,199
-45% -$592K 0.13% 177
2023
Q2
$1.46M Sell
22,798
-6,555
-22% -$419K 0.13% 163
2023
Q1
$2.03M Buy
29,353
+1,791
+6% +$124K 0.17% 119
2022
Q4
$1.98B Buy
27,562
+3,923
+17% +$282M 0.17% 115
2022
Q3
$1.68M Buy
23,639
+8,871
+60% +$631K 0.16% 118
2022
Q2
$1.14M Sell
14,768
-775
-5% -$59.7K 0.12% 133
2022
Q1
$1.14M Buy
15,543
+429
+3% +$31.3K 0.1% 166
2021
Q4
$936K Buy
15,114
+604
+4% +$37.4K 0.08% 198
2021
Q3
$859K Buy
14,510
+53
+0.4% +$3.14K 0.09% 181
2021
Q2
$886K Buy
14,457
+35
+0.2% +$2.15K 0.12% 147
2021
Q1
$910K Buy
14,422
+1,456
+11% +$91.9K 0.12% 172
2020
Q4
$803K Buy
12,966
+1,211
+10% +$75K 0.11% 172
2020
Q3
$691K Buy
11,755
+423
+4% +$24.9K 0.1% 184
2020
Q2
$666K Sell
11,332
-1,491
-12% -$87.6K 0.12% 189
2020
Q1
$715K Buy
12,823
+307
+2% +$17.1K 0.14% 157
2019
Q4
$803K Sell
12,516
-3,570
-22% -$229K 0.14% 174
2019
Q3
$816K Buy
16,086
+1,666
+12% +$84.5K 0.16% 161
2019
Q2
$654K Buy
14,420
+5,102
+55% +$231K 0.13% 183
2019
Q1
$445K Sell
9,318
-4,658
-33% -$222K 0.09% 225
2018
Q4
$726K Sell
13,976
-6,182
-31% -$321K 0.18% 142
2018
Q3
$1.25M Sell
20,158
-53
-0.3% -$3.29K 0.28% 83
2018
Q2
$1.12M Buy
20,211
+7,383
+58% +$408K 0.27% 91
2018
Q1
$811K Buy
12,828
+1,703
+15% +$108K 0.27% 100
2017
Q4
$682K Buy
11,125
+746
+7% +$45.7K 0.22% 126
2017
Q3
$662K Buy
10,379
+1,597
+18% +$102K 0.26% 120
2017
Q2
$489K Buy
+8,782
New +$489K 0.22% 125
2016
Q1
Sell
-3,028
Closed -$208K 147
2015
Q4
$208K Buy
+3,028
New +$208K 0.13% 117